Pre-pubertal Low Dose Transdermal Estradiol in Turner Syndrome
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Children's National Research Institute
- Study ID
- NCT07784582
- Phase
- PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Primary Ovarian Insufficiency
- Turner Syndrome
Eligibility Criteria
- Sex
- FEMALE
- Age
- 8 Years - 12 Years
- Healthy Volunteers
- Not accepted
Interventions
- Estradiol transdermal patch 0.025mg/24 hours- 1/8th fractionated patch — DRUGEstradiol transdermal patch 0.025mg/24 hours- 1/8th fractionated patch will be applied and changed weekly for 6 months
Study Details
This is a research study to find out if treatment with transdermal estradiol patches started between 8 to 11.5 years is safe in girls with Turner syndrome who have ovarian failure and to see whether it may improve performance on two tests of working speed and short-term memory.
Key Dates
- First listed
- Aug 25, 2026
- Start date
- Sep 1, 2026
- Status verified
- Aug 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 15 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Estradiol TreatmentPatients opt to receive 6 months of transdermal ultra low dose estradiol treatment
Primary Outcome Measure
Pattern Comparison processing speed test [ Time Frame: 6 months ]
Central Contacts
- Roopa Kanakatti Shankar, MBBS, MS202-476-2121
- Kimberly Pitner, MSHS, BSN, RN202-476-1403
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's National Hospital | Washington D.C. | District of Columbia | 20010 | Roopa Kanakatti Shankar, MBBS, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Washington D.C., DC
By research site
Related Studies
- Inspiring New Science In Guiding Healthcare in Turner Syndrome RegistryRecruiting · University of Colorado, Denver · Aurora, Colorado
- Vosoritide for Short Stature in Turner SyndromePHASE2 · Recruiting · Roopa Kanakatti Shankar, MBBS, MS · Washington D.C., District of Columbia
- Natural History of Noncirrhotic Portal HypertensionRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- UTHealth Turner Syndrome Research RegistryRecruiting · The University of Texas Health Science Center, Houston · Houston, Texas